Cancer Induces a Stress Ileopathy Depending on β-Adrenergic Receptors and Promoting Dysbiosis that Contributes to Carcinogenesis
Year: 2021
Type: article
Abstract: Gut dysbiosis has been associated with intestinal and extraintestinal malignancies, but whether and how carcinogenesis drives compositional shifts of the microbiome to its own benefit remains an open conundrum. Here, we show that malignant processes can cause ileal mucosa atrophy, with villous microvascular constriction associated with dominance of sympathetic over cholinergic signaling. The rapid onset of tumorigenesis induced a burst of REG3γ release by ileal cells, and transient epithelial barrier permeability that culminated in overt and long-lasting dysbiosis dominated by Gram-positive Clostridium species. Pharmacologic blockade of β-adrenergic receptors or genetic deficiency in Adrb2 gene, vancomycin, or cohousing of tumor bearers with tumor-free littermates prevented cancer-induced ileopathy, eventually slowing tumor growth kinetics. Patients with cancer harbor distinct hallmarks of this stress ileopathy dominated by Clostridium species. Hence, stress ileopathy is a corollary disease of extraintestinal malignancies requiring specific therapies. SIGNIFICANCE: Whether gut dysbiosis promotes tumorigenesis and how it controls tumor progression remain open questions. We show that 50% of transplantable extraintestinal malignancies triggered a β-adrenergic receptor-dependent ileal mucosa atrophy, associated with increased gut permeability, sustained Clostridium spp.-related dysbiosis, and cancer growth. Vancomycin or propranolol prevented cancer-associated stress ileopathy. This article is highlighted in the In This Issue feature, p. 873.
Source: Cancer Discovery
Authors: Satoru Yonekura, Safae Terrisse, Carolina Alves Costa Silva, Antoine Lafarge, Valerio Iebba, Gladys Ferrere, Anne-Gaëlle Goubet, Jean-Eudes Fahrner, Imran Lahmar, Kousuke Ueda, Gibrail Mansouri, Eugénie Pizzato, Pierre Ly, Marine Mazzenga, Cassandra Thelemaque, Marine Fidelle, Fanny Jaulin, Jérôme Cartry, Marc Deloger, Marine Aglave, Nathalie Droin, Paule Opolon, Angélique Puget, Fanny Mann, Michel Neunlist, Anne Bessard, Laetitia Aymeric, Tamara Matysiak-Budnik, Jacques Bosq, Paul Hofman, Connie P.M. Duong, Sophie Ugolini, Valentin Quiniou, Sylvie Berrard, Bernhard Ryffel, Oliver Kepp, Guido Kroemer, Bertrand Routy, Leonardo Lordello, Mohamed-Amine Bani, Nicola Segata, Fjodor Yousef Yengej, Hans Clevers, Jean-Yves Scoazec, Edoardo Pasolli, Lisa Derosa, Laurence Zitvogel
Institutions: Inserm, Université Paris-Saclay, Institut Gustave Roussy, La Ligue Contre le Cancer, Université Paris Cité, Sorbonne Université, Centre de Recherche des Cordeliers, University of Trieste, Kurume University, Fondation Gustave Roussy, Centre National de la Recherche Scientifique, Institut de Biologie du Développement Marseille, The Enteric Nervous System in Gut and Brain Disorders, Université d'Angers, Centre Hospitalier Universitaire de Nantes, Université Côte d'Azur, Centre Hospitalier Universitaire de Nice, The University of Melbourne, Centre d’Immunologie de Marseille-Luminy, NeuroDiderot, Université d'Orléans, Immunologie et Neurogénétique Expérimentales et Moléculaires, Karolinska University Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Karolinska Institutet, Assistance Publique – Hôpitaux de Paris, Hôpital Européen Georges-Pompidou, Centre Hospitalier de l’Université de Montréal, Université de Montréal, University of Trento, European Institute of Oncology, Royal Netherlands Academy of Arts and Sciences, University Medical Center Utrecht, Oncode Institute, University of Naples Federico II
Language: English
Topic: Gut microbiota and health
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: hybrid
Funders: Association pour la Recherche sur le Cancer, Seerave Foundation, Fondation Philanthropia, E-Rare, European Commission, Agence Nationale de la Recherche, Fondation Leducq, Institut National de la Santé et de la Recherche Médicale, Fondation pour la Recherche Médicale, Fondation ARC pour la Recherche sur le Cancer, Ligue Contre le Cancer, Centre National de la Recherche Scientifique, Institut Universitaire de France, Institut National Du Cancer, Institut Gustave-Roussy, Fondation Gustave Roussy, European Research Area Network on Cardiovascular Diseases, Royal Holloway, University of London, High-end Foreign Experts Recruitment Plan of China, Labex Immuno-Oncology
Awards: G1056382719, G1383179533, G2114920166, Gut OncoMicrobiome Signatures (GOMS) associated with cancer incidence, prognosis and prediction of treatment response., G2786066923, Immuno-Oncology, G434337789, PRecISion Medicine Institute in oncology, Regulation of ileal immune responses in the immunosurveillance of colon cancer: role of DAMPs, PAMPs, and self antigens., G8312322146, LUMIERE, G8478118240, Université de Paris
OpenAlex ID: W4200119638
